checkAd

     143  0 Kommentare AXIM Biotechnologies Releases Rapid NeuCovix Test Results Showing Strong Agreement with COVID-19-Based Neutralization Tests - Seite 3

    CONTACT:
    Public Relations Contact:
    Andrew Hard
    Chief Executive Officer CMW Media
    P. 858-264-6600
    andrew.hard@cmwmedia.com 
    www.cmwmedia.com 

    AXIM Corporate Contact Info:
    6191 Cornerstone Ct., Ste. 114
    San Diego, CA 92121, USA
    P. 858-923-4422

    Lesen Sie auch

    Investor Relations Contact:
    investors@aximbiotech.com
    888-759-0844



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    AXIM Biotechnologies Releases Rapid NeuCovix Test Results Showing Strong Agreement with COVID-19-Based Neutralization Tests - Seite 3 SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) - AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announces the completion of …